1,222.50p-171.00 (-12.27%)06 Nov 2025, 14:19
Jump to:
Smith & Nephew PLC Fundamentals
| Company Name | Smith & Nephew PLC | Last Updated | 2025-11-06 |
|---|---|---|---|
| Industry | Medical Devices | Sector | Healthcare |
| Shares in Issue | 847.807 m | Market Cap | £10.40 bn |
| PE Ratio | 32.52 | Dividend per Share | $0.38 |
| Dividend Yield | 2.06 | Dividend Cover | 1.23 |
| EPS | $0.47 | EPS Growth (%) | 0.32 |
| PEG | 0.89 | DPS Growth (%) | 0.0249 |
| Debt Ratio | 0.3230 | Debt Equity Ratio | 0.5956 |
| Asset Equity Ratio | 1.9314 | Cash Equity Ratio | 0.1221 |
| Quick Ratio | 1.3699 | Current Ratio | 3.00 |
| Price To Book Value | 2.7786 | ROCE | 0 |
Smith & Nephew PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| Interim | 2025-10-02 | 2025-11-07 | GBP | 0.1126 | |
| Prelim | 2025-03-27 | 2025-05-28 | GBP | 0.1748 | |
| Interim | 2024-10-03 | 2024-11-08 | GBP | 0.1110 | |
| Prelim | 2024-03-28 | 2024-05-22 | GBP | 0.1849 | |
| Interim | 2023-10-05 | 2023-11-01 | GBP | 0.1189 | |
| Prelim | 2023-03-30 | 2023-05-17 | GBP | 0.1838 |
Smith & Nephew PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | $1.42 bn | $1.47 bn | $1.46 bn |
| Intangible Assets | $4.06 bn | $4.10 bn | $4.27 bn |
| Investments | $16.00 m | $24.00 m | $58.00 m |
| Total Fixed Assets | $5.93 bn | $5.96 bn | $6.11 bn |
| Stocks | $2.39 bn | $2.40 bn | $2.21 bn |
| Debtors | $1.21 bn | $1.18 bn | $1.14 bn |
| Cash & Equivalents | $619.00 m | $302.00 m | $350.00 m |
| Other Assets | $437.00 m | $361.00 m | $330.00 m |
| Total Assets | $10.35 bn | $9.99 bn | $9.97 bn |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | $1.53 bn | $2.27 bn | $1.72 bn |
| Creditors after 1 year | $3.56 bn | $2.50 bn | $2.99 bn |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $5.09 bn | $4.77 bn | $4.71 bn |
| Net assets | $5.26 bn | $5.22 bn | $5.26 bn |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | $175.00 m | $175.00 m | $175.00 m |
| Share Premium | $635.00 m | $635.00 m | $635.00 m |
| Profit / Loss | $498.00 m | $290.00 m | $235.00 m |
| Other Equity | $5.26 bn | $5.22 bn | $5.26 bn |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | $5.26 bn | $5.22 bn | $5.26 bn |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | $0.38 | $0.31 | $0.34 |
| Debt-to-Equity | $0.62 | $0.44 | $0.52 |
| Assets / Equity | 1.9314 | 1.9314 | 1.9314 |
| Cash / Equity | 0.1221 | 0.1221 | 0.1221 |
| EPS | $0.66 | $0.51 | $0.46 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | $987.00 m | $608.00 m | $468.00 m |
| Cashflow before financing | $901.00 m | $408.00 m | -$458.00 m |
| Increase in Cash | $332.00 m | -$40.00 m | -$930.00 m |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | $5.81 bn | $5.55 bn | $5.21 bn |
| Cost of sales | $1.76 bn | $1.73 bn | $1.54 bn |
| Gross Profit | $4.05 bn | $3.82 bn | $3.67 bn |
| Operating Profit | $657.00 m | $425.00 m | $450.00 m |
| Pre-Tax profit | $498.00 m | $290.00 m | $235.00 m |
Smith & Nephew PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder. |
| Latest Interim Date | 5 Aug 2025 |
| Latest Fiscal Year End Date | 25 Feb 2025 |
Smith & Nephew PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2025-08-20 | Mr. David P King | Non-Executive Director |
| 2018-04-12 | Mr. Joseph C. Papa, M.B.A.,R.Ph. | Independent Director |
| 2025-08-26 | Mr. Marc E. Owen | Non-Executive Director |
| 2019-04-11 | Dr. Michael A. Friedman M.D. | Non-Executive Director |
| 2018-05-07 | Mr. Olivier Bohuon | Executive Director,Chief Executive Officer |
| 2014-07-31 | Dr. Pamela Josephine Kirby | Non-Executive Director |
| 2007-02-15 | Mr. Warren Decatur Knowlton | Non-Executive Director |
| 2012-12-31 | Mr. Adrian Nevil Hennah | Executive Director,Chief Financial Officer |
| 2017-04-06 | Mr. Brian Paul Larcombe | Independent Non-Executive Director |
| 2012-03-01 | Mr. David J. Illingworth | Chief Executive Officer |
| 2024-01-04 | Mr. Erik Engstrom | Non-Executive Director |
| 2014-04-10 | Mr. Richard Urbain de Schutter | Senior Independent Non-Executive Director |
| 2023-03-06 | Mr. Robin Anthony David Freestone | Non-Executive Director |
| 2004-12-16 | Dr. Rolf Wilhelm Heinrich Stomberg | Independent Non-Executive Director |
| 2025-08-26 | Mr. Simon Jonathan Lowth | Non-Executive Director |
| 2011-08-09 | Sir Christopher John O'Donnell | Executive Director |
| 2019-04-11 | Mr. Ian E. Barlow | Non-Executive Director |
| 2023-09-15 | Mr. Roberto Quarta | Non-Executive Director,Chairman |
| 2014-04-10 | Sir John Buchanan | Non-Executive Director,Chairman |
| 2024-05-09 | Mr. Charles Richard Medlock | Non-Executive Director |
| 2025-02-24 | Mr. Rupert C Soames OBE | Non-Executive Director,Chairman |
| 2025-08-26 | Mr. Jeremy Kim Maiden | Non-Executive Director |
| 2025-08-26 | Ms. Angie Risley | Non-Executive Director,Senior Independent non-executive director |
| 2012-11-01 | Ms. Genevieve Berger | Non-Executive Director |
| 2025-03-27 | Mr. John Terence Rogers | Executive Director,Chief Financial Officer |
| 2021-04-14 | The Right Honourable Baroness Virginia Bottomley of Nettlestone, PC DL | Non-Executive Director |
| 2014-03-24 | Mr. Ajay G Piramal | Independent Non-Executive Director |
| 2018-03-05 | Ms. Julie Brown | Executive Director,Chief Financial Officer |
| 2025-08-26 | Ms. Joanna Christine Hallas | Non-Executive Director |
| 2019-10-31 | Mr. Namal Nawana | Executive Director,Chief Executive Officer |
| 2024-03-29 | Ms. Anne-Francoise Nesmes | Executive Director,Chief Financial Officer |
| 2021-03-01 | Ms. Vinita Bali | Non-Executive Director |
| 2025-08-26 | Dr. Katarzyna Mazur-Hofsaess, PhD | Non-Executive Director |
| 2025-08-22 | Ms. Sybella Jane Stanley | Non-Executive Director |
| 2025-08-20 | Mr. Deepak S. Nath | Executive Director,Chief Executive Officer |
| 2020-04-09 | Mr. Graham Timothy Baker | Executive Director,Chief Financial Officer |
| 2025-04-30 | Mr. Robert Jon White | Non-Executive Director |
| 2023-03-06 | Mr. Roland Daniel Diggelmann | Executive Director,Chief Executive Officer |
| 2025-08-26 | Dr. John Ma | Non-Executive Director |
Smith & Nephew PLC Contact Details
| Company Name | Smith & Nephew PLC |
|---|---|
| Address | Hatters Lane, Building 5, Croxley Park, Watford, WD18 8YE |
| Telephone | +44 7811270734 |
| Website | https://www.smith-nephew.com |
Smith & Nephew PLC Advisors
| Registrar | Computershare Investor Services PLC |
|---|---|
| Phone | +44 3707020003 |
| Fax | +44 3707036101 |
| Auditor | KPMG |
|---|---|
| Phone | +44 2073111000 |
| Fax | +44 2073113311 |
| Stockbroker | Bank of America Merrill Lynch |
|---|---|
| Phone | +44 2076281000 |
| Fax | +44 2078672867 |
| Financial PR Adviser | FTI Consulting Inc |
|---|---|
| Phone | +44 2037271000 |
| Fax | +44 2037271007 |
| Bank | National Westminster Bank PLC |
|---|
| Stockbroker | J.P. Morgan Cazenove Ltd |
|---|---|
| Phone | +44 2077424000 |
| Bank | Lloyds Bank PLC |
|---|
| Remuneration Consultant | Willis Towers Watson |
|---|---|
| Phone | +44 2071702000 |
| Fax | +44 2071702222 |
| Solicitor | Ashurst LLP |
|---|---|
| Phone | +44 2076381111 |
| Fax | +44 2076381112 |
| Solicitor | Freshfields Bruckhaus Deringer |
|---|---|
| Phone | +44 2079364000 |
| Fax | +44 2078327001 |
| Solicitor | Pinsent Masons LLP |
|---|---|
| Phone | +44 2074187000 |
| Fax | +44 2074187050 |
| Solicitor | Squire Patton Boggs |
|---|---|
| Phone | +44 2076551000 |
| Fax | +44 2076551001 |
| Bank | Chase Manhattan Bank N.A. (The) |
|---|
| Auditor | EY |
|---|---|
| Phone | +44 2079512000 |
| Fax | +44 2079511345 |
| Auditor | Ernst & Young LLP |
|---|
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Helios Towers PLC | 178.00 | 14.84 |
| Ceres Power Holdings PLC | 399.80 | 7.53 |
| Rs Group PLC | 589.00 | 6.61 |
| Sainsbury (J) PLC | 357.00 | 5.87 |
| Imi PLC | 2,528.85 | 5.28 |
| Watches Of Switzerland Group PLC | 409.00 | 4.87 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Smith & Nephew PLC | 1,223.42 | -12.21 |
| Hikma Pharmaceuticals PLC | 1,582.00 | -10.67 |
| Tbc Bank Group PLC | 3,895.00 | -9.31 |
| Ashmore Group PLC | 171.11 | -8.69 |
| Metlen Energy & Metals PLC | 42.70 | -7.48 |
| Diageo PLC | 1,691.50 | -5.90 |